Wugen
Jonathan Hall has worked in the scientific field since 2009. Jonathan began their career at R & D Systems as a Research Associate, where they performed routine and complex bioassays and ELISAs for quality control on proteins, receptors, and antibodies. In 2015, they joined MedImmune as an Associate Scientist I, where they developed bioanalytical methods for measuring potency of biopharmaceuticals and designed, executed, and analyzed experiments. In 2019, Jonathan moved to PPD as an Associate Research Scientist, where they were responsible for regulatory and scientific conduct of development, validation, stability projects, and/or other specialty technologies. Jonathan is currently employed at Wugen as a Senior Scientist.
Jonathan Hall attended the University of Minnesota from 2005 to 2008, where they earned a Bachelor of Science in Neuroscience.
This person is not in any offices
Wugen
Wugen is a clinical stage immuno-oncology cell therapy company, developing off-the-shelf NK and CAR-T cell therapies for the treatment of both solid tumor and heme malignancies.